We are pleased to announce the closing of Longitude Venture Partners IV, L.P.

Learn more
Learn more
×
Longitude Capital
  • ABOUT
  • TEAM
  • PORTFOLIO
  • NEWS
  • CONTACT
  • LP LOGIN
Select Page

Kala Pharmaceuticals Announces Availability of EYSUVIS™ for the Treatment of Dry Eye Disease and Provides Update on Development Pipeline

by Seini Moimoi | Jan 7, 2021 | Portfolio News

Vaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential of VAX-A1, a Novel Conjugate Vaccine Designed to Prevent Group A Strep Infections

by Seini Moimoi | Jan 6, 2021 | Portfolio News

Inozyme Pharma Announces Authorization to Proceed in U.S. and U.K. with Phase 1/2 Clinical Trial of INZ-701 for the Treatment of ENPP1 Deficiency

by Seini Moimoi | Jan 4, 2021 | Portfolio News

Checkmate Pharmaceuticals Announces Key Additions to Executive Management Team

by Seini Moimoi | Jan 4, 2021 | Portfolio News

WelbeHealth Administers First Shipment of COVID-19 Vaccines to Most Vulnerable Seniors

by Seini Moimoi | Dec 31, 2020 | Portfolio News

Orbus Therapeutics Receives U.S. Patent for Eflornithine Formulations

by Seini Moimoi | Dec 23, 2020 | Portfolio News

« Older Entries

Media Contact

Maggie Jamison

mjamison@longitudecapital.com

650-854-5700

  • Facebook
  • Twitter
  • Google
  • RSS
footer-logo

LP Login

© 2021 Longitude Capital. All rights reserved.
  • Privacy Policy
  • Disclaimer